In the US, Dronedarone (dronedarone systemic) is a member of the drug class group III antiarrhythmics and is used to treat Atrial Fibrillation and Atrial Flutter.
US matches:
- Dronedarone
Scheme
Rec.INN
CAS registry number (Chemical Abstracts Service)
0141626-36-0
Chemical Formula
C31-H44-N2-O5-S
Molecular Weight
556
Therapeutic Category
Antiarrhythmic agent
Chemical Names
Methanesulfonamide, N-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]-
N,N-dibutyl-3-[4-[(2-butyl-5-methylsulfonamido)benzofuran-3-ylcarbonyl]phenoxy]propylamine
N-[2-butyl-3-[p-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]methanesulfonamide (WHO)
Foreign Names
- Dronedaronum (Latin)
- Dronedaron (German)
- Dronédarone (French)
- Dronedarona (Spanish)
Generic Names
- SR-33589 (IS)
- UNII-JQZ1L091Y2 (IS)
- Dronedarone hydrochloride (OS: USAN)
- SR33598B (IS)
- UNII-FA36DV299Q (IS)
Brand Names
- Multaq
Sanofi-Aventis, Brazil; Sanofi-Aventis, Switzerland; Sanofi-Aventis, Germany; Sanofi-Aventis, United Kingdom; Sanofi-Aventis, United States
International Drug Name Search
Glossary
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment